Literature DB >> 32304212

Letter: Transmission of COVID-19 During Neurosurgical Procedures-Some Thoughts From the United Kingdom.

Alistair Jenkins1.   

Abstract

Entities:  

Year:  2020        PMID: 32304212      PMCID: PMC7188153          DOI: 10.1093/neuros/nyaa126

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


× No keyword cloud information.
To the Editor: While in every country we should be limiting surgery to urgent procedures, patients will still need surgery. There has been concern about the transmission of COVID-19 during neurosurgical operations, particularly those involving drills or endoscopes. Like most advice in the current crisis, the following is based on a synthesis of national and international guidelines, published evidence, expert opinion, and common sense; similarly, like most, it may be subject to change as we learn more about this devastating illness. If local circumstances permit, the Society of British Neurological Surgeons (SBNS) strongly advocates personal protection equipment (PPE) for all procedures during this time. However, COVID-19 appears to be principally spread, either directly or via fomites, through droplets from respiratory epithelium—especially the upper respiratory tract. Blood is not at this point a recognized vehicle; if significant virus were present in blood, we would be able to do a blood test for the disease. Similarly, it does not seem to concentrate in the cerebrospinal fluid. Thus, most neurosurgical procedures to the spine and head should be safe with routine face and eye protection if PPE is unavailable. This includes cranial and spinal drilling, though we should all be more rigorous than usual with the irrigation of drills to prevent aerosol formation. Care would clearly be needed with anterior skull base procedures, which might breach an air sinus. Endonasal procedures, by contrast, are a very significant risk. Use of debriders and drills within the nasal cavity will produce a droplet aerosol, which is highly dangerous. In Wuhan, ENT surgeons are amongst the worst affected—and N95 masks did not prevent infection. The majority of pituitary patients present subacutely, and can hopefully wait, but it would be unforgivable to allow a patient to go blind during this period. With patients for whom surgery cannot be deferred, consideration should be given to alternatives to endoscopic surgery: Craniotomy Microscope-based trans-sphenoidal surgery, with a submucosal approach and entry to the sella using nondrill techniques. Available PPE should be employed BY ALL THEATRE STAFF and care taken with nasal secretions. If these are unavailable in a particular unit, or there is insufficient experience, networking should be employed. Preoperative COVID-19 testing should be employed when available. The small number of patients presenting in an endocrine crisis should be managed medically if at all possible. If there is no alternative to trans-sphenoidal surgery, it is the strong feeling of the SBNS that this should be discussed at a national level.

Summary

From the information currently available, routine cranial and spinal cases are safe to perform. Endoscopic endonasal surgery is NOT safe and should be avoided.

Disclosures

The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.
  4 in total

1.  Endoscopic endonasal skull base surgery during the COVID-19 pandemic: A developing country perspective.

Authors:  Mohamed A R Soliman; Mohammad Elbaroody; Amr K Elsamman; Mohamed Ibrahim Refaat; Ehab Abd-Haleem; Walid Elhalaby; Hazem Gouda; Amr Safwat; Mohamed El Shazly; Hisham Lasheen; AbdelRahman Younes; Yousry El-Hemily; Ahmed Elsaid; Haitham Kandel; Mohamed Lotfy; Ehab El Refaee
Journal:  Surg Neurol Int       Date:  2020-09-25

2.  A safe approach to surgery for pituitary and skull base lesions during the COVID-19 pandemic.

Authors:  Angelos Kolias; James Tysome; Neil Donnelly; Rishi Sharma; Effrossyni Gkrania-Klotsas; Karol Budohoski; Silvia Karcheva; Ram Adapa; Indu Lawes; Mark Gurnell; Peter Hutchinson; Manohar Bance; Patrick Axon; Thomas Santarius; Richard J Mannion
Journal:  Acta Neurochir (Wien)       Date:  2020-05-09       Impact factor: 2.216

3.  Aerosolisation in endonasal endoscopic pituitary surgery.

Authors:  Rana S Dhillon; Lana V Nguyen; Wagih Abu Rowin; Ruhi S Humphries; Kevin Kevin; Jason D Ward; Andrew Yule; Tuong D Phan; Yi Chen Zhao; David Wynne; Peter M McNeill; Nicholas Hutchins; David A Scott
Journal:  Pituitary       Date:  2021-01-19       Impact factor: 4.107

4.  The Roadmap to Pituitary in COVID-19 Crisis.

Authors:  Manjul Tripathi; Rajesh Chhabra; Pinaki Dutta; Liza Das; Sandeep Mohindra; Satyvati Mohindra; Sonikpreet Aulakh
Journal:  Neurol India       Date:  2020 May-Jun       Impact factor: 2.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.